# LEC Proliferation in Vivo and In-vitro

> **NCT03857685** · — · UNKNOWN · sponsor: **Prim. Prof. Dr. Oliver Findl, MBA** · enrollment: 40 (estimated)

## Conditions studied

- Posterior Capsule Opacification

## Interventions

- **PROCEDURE:** In-vitro model

## Key facts

- **NCT ID:** NCT03857685
- **Lead sponsor:** Prim. Prof. Dr. Oliver Findl, MBA
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2020-05-01
- **Final completion:** 2021-01-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03857685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03857685, "LEC Proliferation in Vivo and In-vitro". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03857685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*